• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者磁共振淋巴造影中淋巴结转移的地理分布。

Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients.

机构信息

Department of Radiation Oncology, Radbound University Nijmegen, Medical Centre, Nijmegen, The Netherlands.

出版信息

Radiother Oncol. 2013 Jan;106(1):59-63. doi: 10.1016/j.radonc.2012.10.021. Epub 2012 Nov 27.

DOI:10.1016/j.radonc.2012.10.021
PMID:23199653
Abstract

PURPOSE

To investigate the pattern of lymph node spread on magnetic resonance lymphography (MRL) in prostate cancer patients and compare this pattern to the clinical target volume for elective pelvis irradiation as defined by the radiation therapy oncology group (RTOG-CTV).

METHODS AND MATERIALS

The charts of 60 intermediate and high risk prostate cancer patients with non-enlarged positive lymph nodes on MRL were reviewed. Positive lymph nodes were assigned to a lymph node region according to the guidelines for delineation of the RTOG-CTV. Five lymph node regions outside this RTOG-CTV were defined: the para-aortal, proximal common iliac, pararectal, paravesical and inguinal region.

RESULTS

Fifty-three percent of the patients had an MRL-positive lymph node in a lymph node region outside the RTOG-CTV. The most frequently involved aberrant sites were the proximal common iliac, the pararectal and para-aortal region, which were affected in 30%, 25% and 18% respectively.

CONCLUSION

More than half of the patients had an MRL-positive lymph node outside the RTOG-CTV. To reduce geographical miss while minimizing the toxicity of radiotherapy, image based definition of an individual target volume seems to be necessary.

摘要

目的

研究前列腺癌患者磁共振淋巴造影(MRL)上淋巴结转移的模式,并将其与放射治疗肿瘤学组(RTOG-CTV)定义的选择性骨盆照射的临床靶区(CTV)进行比较。

方法和材料

回顾了 60 例中高危前列腺癌患者的病历,这些患者在 MRL 上的淋巴结肿大呈阳性,但淋巴结无肿大。阳性淋巴结根据 RTOG-CTV 的勾画指南分配到淋巴结区域。在这个 RTOG-CTV 之外定义了五个淋巴结区域:腹主动脉旁、近端髂总、直肠旁、膀胱旁和腹股沟区。

结果

53%的患者在 RTOG-CTV 之外的淋巴结区域有 MRL 阳性淋巴结。最常受累的异常部位是近端髂总、直肠旁和腹主动脉旁区域,分别受累 30%、25%和 18%。

结论

超过一半的患者在 RTOG-CTV 之外有 MRL 阳性淋巴结。为了减少照射野的地理缺失,同时最大限度地降低放疗毒性,似乎需要基于图像定义个体化靶区。

相似文献

1
Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients.前列腺癌患者磁共振淋巴造影中淋巴结转移的地理分布。
Radiother Oncol. 2013 Jan;106(1):59-63. doi: 10.1016/j.radonc.2012.10.021. Epub 2012 Nov 27.
2
High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.根治性前列腺切除术后生化复发的前列腺癌患者,磁共振淋巴造影显示异常淋巴结转移发生率高。
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1405-10. doi: 10.1016/j.ijrobp.2011.04.054. Epub 2011 Jun 2.
3
Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram.前列腺切除术后生化复发患者的磁共振淋巴造影表现与 Stephenson 列线图的关系。
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1186-91. doi: 10.1016/j.ijrobp.2012.02.039. Epub 2012 Apr 18.
4
Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.PET/CT 和 MR 淋巴造影术在治疗前列腺癌淋巴结转移患者中的价值。
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):712-8. doi: 10.1016/j.ijrobp.2011.12.093. Epub 2012 Mar 13.
5
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).前列腺癌放疗中淋巴结区的定义:法国泌尿生殖系统肿瘤学组和法国泌尿外科协会的文献批判性回顾。
Cancer Treat Rev. 2015 Dec;41(10):814-20. doi: 10.1016/j.ctrv.2015.10.005. Epub 2015 Oct 23.
6
Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.基于前哨淋巴结SPECT成像进行靶区定义的高危前列腺癌调强放射治疗。
BMC Cancer. 2005 Jul 28;5:91. doi: 10.1186/1471-2407-5-91.
7
Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer.磁共振淋巴造影引导下前列腺癌选择性高剂量淋巴结照射。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):175-83. doi: 10.1016/j.ijrobp.2010.09.023. Epub 2010 Nov 13.
8
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.前列腺淋巴结分布:一份源自PET/CT的前列腺癌患者手术治疗前后的解剖图谱。
Radiat Oncol. 2016 Mar 11;11:37. doi: 10.1186/s13014-016-0615-9.
9
Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.基于钆喷酸葡胺增强磁共振成像的放射治疗计划盆腔淋巴结地形图。
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):844-51. doi: 10.1016/j.ijrobp.2008.09.026. Epub 2008 Dec 25.
10
Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.钆特酸葡甲胺 10MR 淋巴造影术在 PSA 复发后接受图像引导、剂量递增淋巴结放疗的患者中的目标定义和随访中的应用。
Strahlenther Onkol. 2011 Mar;187(3):206-12. doi: 10.1007/s00066-010-2195-1. Epub 2011 Feb 21.

引用本文的文献

1
Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost.对于接受近距离放疗强化治疗的高危前列腺癌患者,前列腺外剂量与更好的治疗结果相关。
Front Oncol. 2023 Jun 15;13:1200676. doi: 10.3389/fonc.2023.1200676. eCollection 2023.
2
Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC).经尿道膀胱肿瘤电切术(TURBT)治疗非肌层浸润性膀胱癌(NMIBC)后前列腺尿道复发。
Clin Case Rep. 2022 Jan 8;10(1):e05256. doi: 10.1002/ccr3.5256. eCollection 2022 Jan.
3
Cancer nanotechnology: current status and perspectives.
癌症纳米技术:现状与展望。
Nano Converg. 2021 Nov 2;8(1):34. doi: 10.1186/s40580-021-00282-7.
4
Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost for Clinically Node-Positive Prostate Cancer: A Single-Institutional Retrospective Study.调强放射治疗同步整合加量用于临床淋巴结阳性前列腺癌:一项单机构回顾性研究
Cancers (Basel). 2021 Jul 31;13(15):3868. doi: 10.3390/cancers13153868.
5
Head-to-Head Comparison of Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10-Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients.前列腺特异性膜抗原 PET/CT 与 Ferumoxtran-10 增强 MRI 对头对头比较用于诊断前列腺癌患者淋巴结转移。
J Nucl Med. 2021 Sep 1;62(9):1258-1263. doi: 10.2967/jnumed.120.258541. Epub 2021 Jan 30.
6
The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy.前列腺癌盆腔淋巴结转移的分布揭示了推进和个性化盆腔放疗的潜力。
Front Oncol. 2021 Jan 8;10:590722. doi: 10.3389/fonc.2020.590722. eCollection 2020.
7
Magnetic resonance imaging at ultra-high magnetic field strength: An in vivo assessment of number, size and distribution of pelvic lymph nodes.超高磁场磁共振成像:盆腔淋巴结数量、大小和分布的体内评估。
PLoS One. 2020 Jul 31;15(7):e0236884. doi: 10.1371/journal.pone.0236884. eCollection 2020.
8
Pattern of metastatic deposit in recurrent prostate cancer: a whole-body MRI-based assessment of lesion distribution and effect of primary treatment.复发性前列腺癌转移灶模式:基于全身 MRI 的病变分布评估及原发治疗效果。
World J Urol. 2019 Dec;37(12):2585-2595. doi: 10.1007/s00345-019-02700-2. Epub 2019 Mar 2.
9
Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer.用于高危前列腺癌淋巴结分期的超小型超顺磁性氧化铁造影剂。
Transl Androl Urol. 2018 Sep;7(Suppl 4):S453-S461. doi: 10.21037/tau.2018.05.15.
10
Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block.超小超顺磁性氧化铁在转移性淋巴结检测中的应用:重新受到关注。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jan;10(1). doi: 10.1002/wnan.1471. Epub 2017 Apr 6.